G

GenSight Biologics

61 employees

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Genetics
Medical

Date founded

2013

Funding rounds raised

Total raised

$42M

from 20 investors over 20 rounds

G

GenSight Biologics raised $6.6M on August 3, 2023

Investors: The Invus Group, UPMC Enterprises and Sofinnova Partners

G

GenSight Biologics raised $35M on November 7, 2022

Investors: European Investment Bank

G

GenSight Biologics raised $25M on October 22, 2020

Investors: Arix Bioscience plc, The Invus Group and Sofinnova Partners

G

GenSight Biologics raised $17M on December 20, 2019

Investors: Kreos Capital and Sofinnova Partners

G

GenSight Biologics raised $9.1M on February 25, 2019

Investors: Sofinnova Partners

G

GenSight Biologics raised $36M on July 23, 2015

Investors: HealthCap, Index Ventures, Sphera Fund, Abingworth, Perceptive Advisors, Versant Ventures and Jennison Associates LLC

G

GenSight Biologics raised $42M on April 8, 2013

Investors: Index Ventures, Versant Ventures and Abingworth

FAQ